DailyDoctor Archive Specialties Get app
Back to the 20 September 2026 edition

Clinical update · 02 of 05

The cardiometabolic footprint of the systemic drugs you prescribe most

Baseline and monitor cardiometabolic parameters on systemic dermatology drugs, and agree who owns the follow-up.

A two-part continuing education review sets out what systemic dermatological treatments do to cardiovascular and metabolic health. Part I covers the older workhorses: retinoids and rexinoids, anthracyclines, antifungals, oral minoxidil, methotrexate, ultraviolet phototherapy and colchicine.

The effects run both ways. Some of these agents worsen lipids, glucose handling or cardiac function; others — methotrexate and colchicine among them — carry a plausible protective signal in inflammatory disease. The review pairs the mechanism for each with practical workup and monitoring advice, and argues for routine coordination with cardiology, endocrinology and primary care rather than dermatology managing the consequences alone.

The useful reframing is that a dermatological prescription in a patient with psoriasis, hidradenitis or alopecia lands in someone who already carries raised cardiovascular risk from the disease itself. Oral minoxidil for hair loss is the clearest example of a drug now prescribed at volume, often to otherwise well patients, whose cardiovascular monitoring is inconsistent.

  • Record a baseline lipid profile and fasting glucose before starting systemic retinoids
  • Take a cardiac history and baseline blood pressure and pulse before oral minoxidil, and review at follow-up
  • Check interactions with statins and antihypertensives before starting an azole antifungal
  • Name the monitoring owner explicitly — dermatology or primary care — rather than assuming
  • In psoriasis, treat cardiovascular risk assessment as part of the skin consultation

Why it matters

These prescriptions land in patients whose disease already raises their cardiovascular risk.

Don't overread it

This is a narrative continuing-education review, not new comparative evidence on any one drug.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

psoriasisimmunobulloushaireczemaskincancer

Tomorrow morning, before your first patient

One edition a day for dermatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app